9 Comments
Modern HIV treatments like lenacapavir now allow people to manage the virus with just two injections a year, dramatically improving quality of life and adherence. Viral suppression rates exceed 98%, and global access is expanding - but cost and equity remain critical challenges.
Read More7 Comments
Lamivudine-zidovudine remains a vital, affordable HIV treatment worldwide, especially in low-resource settings. It’s not new, but its reliability, safety in pregnancy, and low cost keep it essential in global health.
Read More14 Comments
Explore how stigma blocks access to Atazanavir and learn practical steps to improve HIV treatment adherence, with comparisons, checklists, and FAQs.
Read More